Inhibition of NO synthase by L - NAME might induce an anti - tumour effect by limiting nutrients and oxygen to reach tumour tissue or affecting vascular growth.	"NO synthase	14	25	Gene_or_gene_product"	"L - NAME	29	37	Chemical"	"tumour	61	67	Cancer"	"oxygen	101	107	Chemical"	"tumour tissue	117	130	Tissue"	"vascular	144	152	Multi"	"[{""token"": ""NO synthase"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - NAME"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""oxygen"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""tumour tissue"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""vascular"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Multi""}]"
In addition, although VEGF receptors were higher in tumors than normal kidney, there was a significant up - regulation of only flt - 1 ( P = 0. 003) but not KDR ( P = 0. 12) or flt - 4 ( P = 0. 09).	"VEGF receptors	22	36	Gene_or_gene_product"	"tumors	52	58	Cancer"	"kidney	71	77	Organ"	"flt - 1	127	134	Gene_or_gene_product"	"KDR	157	160	Gene_or_gene_product"	"flt - 4	177	184	Gene_or_gene_product"	"[{""token"": ""VEGF receptors"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""kidney"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Organ""}, {""token"": ""flt - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"
A significant increase was observed in flt - 1 ( P less than 0. 001), KDR ( P = 0. 02), and flt - 4 ( P = 0. 01) but not VEGF - B ( P = 0. 82) or VEGF - C ( P = 0. 52) expression in clear cell compared with chromophil ( papillary) carcinomas.	"flt - 1	39	46	Gene_or_gene_product"	"KDR	70	73	Gene_or_gene_product"	"flt - 4	92	99	Gene_or_gene_product"	"VEGF - B	121	129	Gene_or_gene_product"	"VEGF - C	146	154	Gene_or_gene_product"	"clear cell	182	192	Cell"	"[{""token"": ""flt - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - B"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""clear cell"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Cell""}]"
PURPOSE: To evaluate alterations in the retinal vasculature overlying pigment epithelial detachments ( PED) in exudative age - related macular degeneration ( ARMD) using indocyanine green and fluorescein angiography.	"retinal vasculature	40	59	Multi"	"pigment epithelial detachments	70	100	Pathological_formation"	"PED	103	106	Pathological_formation"	"macular	135	142	Tissue"	"indocyanine green	170	187	Chemical"	"fluorescein	192	203	Chemical"	"[{""token"": ""retinal vasculature"", ""start_span"": 40, ""end_span"": 59, ""type"": ""Multi""}, {""token"": ""pigment epithelial detachments"", ""start_span"": 70, ""end_span"": 100, ""type"": ""Pathological_formation""}, {""token"": ""PED"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Pathological_formation""}, {""token"": ""macular"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Tissue""}, {""token"": ""indocyanine green"", ""start_span"": 170, ""end_span"": 187, ""type"": ""Chemical""}, {""token"": ""fluorescein"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Chemical""}]"
Control RM - 9 cells and RM - 9 cells stably transfected with IL - 12 gene ( RM - 9 - IL12) were inoculated subcutaneously in 4 - to 6 - week - old male C57BL / J6 mice.	"RM - 9 cells	8	20	Cell"	"RM - 9 cells	25	37	Cell"	"IL - 12	62	69	Gene_or_gene_product"	"IL12	86	90	Gene_or_gene_product"	"subcutaneously	108	122	Immaterial_anatomical_entity"	"C57BL / J6 mice	153	168	Organism"	"[{""token"": ""RM - 9 cells"", ""start_span"": 8, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""RM - 9 cells"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""IL - 12"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL12"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""subcutaneously"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""C57BL / J6 mice"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Organism""}]"
Adaptor protein Crk is required for ephrin - B1 - induced membrane ruffling and focal complex assembly of human aortic endothelial cells.	"Crk	16	19	Gene_or_gene_product"	"ephrin - B1	36	47	Gene_or_gene_product"	"membrane	58	66	Cellular_component"	"focal complex	80	93	Cellular_component"	"human	106	111	Organism"	"aortic endothelial cells	112	136	Cell"	"[{""token"": ""Crk"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 112, ""end_span"": 136, ""type"": ""Cell""}]"
We investigated the mechanism by which ephrin - B1 promotes membrane ruffling in human aortic endothelial cells, because membrane ruffling heralds cell body migration.	"ephrin - B1	39	50	Gene_or_gene_product"	"membrane	60	68	Cellular_component"	"human	81	86	Organism"	"aortic endothelial cells	87	111	Cell"	"membrane	121	129	Cellular_component"	"cell body	147	156	Cell"	"[{""token"": ""ephrin - B1"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 87, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Cellular_component""}, {""token"": ""cell body"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Cell""}]"
Serum deprivation - induced apoptosis of BHK ( + TF) cells was characterized by apoptotic blebs, nuclei with chromatin - condensed bodies, DNA degradation, and activation of caspase 3.	"Serum	0	5	Organism_substance"	"blebs	90	95	Cellular_component"	"nuclei	97	103	Cellular_component"	"chromatin	109	118	Cellular_component"	"DNA	139	142	Cellular_component"	"caspase 3	174	183	Gene_or_gene_product"	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""blebs"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cellular_component""}, {""token"": ""nuclei"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cellular_component""}, {""token"": ""chromatin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Cellular_component""}, {""token"": ""caspase 3"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}]"
This study aimed to explore the correlation between the expression of VEGF - C in TAMs and lymphatic metastasis in human oral squamous - cell carcinoma ( OSCC).	"VEGF - C	70	78	Gene_or_gene_product"	"TAMs	82	86	Cell"	"lymphatic	91	100	Organ"	"human	115	120	Organism"	"oral squamous - cell carcinoma	121	151	Cancer"	"OSCC	154	158	Cancer"	"[{""token"": ""VEGF - C"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""TAMs"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organism""}, {""token"": ""oral squamous - cell carcinoma"", ""start_span"": 121, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Cancer""}]"
An earlier study showed that thrombospondin is expressed in benign prostatic hyperplasia ( BPH) and high - grade prostatic intraepithelial neoplasia ( PIN) but is absent in prostate cancer.	"thrombospondin	29	43	Gene_or_gene_product"	"benign prostatic hyperplasia	60	88	Pathological_formation"	"BPH	91	94	Pathological_formation"	"prostatic intraepithelial neoplasia	113	148	Pathological_formation"	"PIN	151	154	Pathological_formation"	"prostate cancer	173	188	Cancer"	"[{""token"": ""thrombospondin"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""benign prostatic hyperplasia"", ""start_span"": 60, ""end_span"": 88, ""type"": ""Pathological_formation""}, {""token"": ""BPH"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Pathological_formation""}, {""token"": ""prostatic intraepithelial neoplasia"", ""start_span"": 113, ""end_span"": 148, ""type"": ""Pathological_formation""}, {""token"": ""PIN"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Pathological_formation""}, {""token"": ""prostate cancer"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Cancer""}]"
These data complement work that shows that HPV16 E7 also interacts with p600, and that this interaction correlates with the ability of HPV16 E7 to transform cells.	"HPV16	43	48	Organism"	"E7	49	51	Gene_or_gene_product"	"p600	72	76	Gene_or_gene_product"	"HPV16	135	140	Organism"	"E7	141	143	Gene_or_gene_product"	"cells	157	162	Cell"	"[{""token"": ""HPV16"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""HPV16"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Cell""}]"
Constitutive expression of a transfected Hox 1. 4 gene under the control of a simian virus 40 promotor leads to differentiated cell morphology similar to that of the RA - induced phenotype and restores the growth - inhibitory effects of RA in N - ras - transformed cells.	"simian virus 40	78	93	Organism"	"cell	127	131	Cell"	"RA	166	168	Chemical"	"RA	237	239	Chemical"	"N - ras	243	250	Gene_or_gene_product"	"cells	265	270	Cell"	"[{""token"": ""simian virus 40"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""cell"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""RA"", ""start_span"": 237, ""end_span"": 239, ""type"": ""Chemical""}, {""token"": ""N - ras"", ""start_span"": 243, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Cell""}]"
In vitro and in vivo studies with losartan, small interfering RNA specific for calcineurin and FK506 demonstrated that Ang II - mediated sFlt - 1 release was via Ang II type 1 receptor activation and calcineurin signaling, respectively.	"losartan	34	42	Chemical"	"calcineurin	79	90	Gene_or_gene_product"	"FK506	95	100	Chemical"	"Ang II	119	125	Gene_or_gene_product"	"sFlt - 1	137	145	Gene_or_gene_product"	"Ang II type 1 receptor	162	184	Gene_or_gene_product"	"[{""token"": ""losartan"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""calcineurin"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""FK506"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""Ang II"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang II type 1 receptor"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"
In addition, magnolol activated phosphatase and tensin homolog deleted on chromosome 10 ( PTEN) and inactivated Akt by decreasing levels of phosphorylated PTEN and phosphorylated Akt.	"magnolol	13	21	Chemical"	"phosphatase and tensin homolog deleted on chromosome 10	32	87	Gene_or_gene_product"	"PTEN	90	94	Gene_or_gene_product"	"Akt	112	115	Gene_or_gene_product"	"PTEN	155	159	Gene_or_gene_product"	"Akt	179	182	Gene_or_gene_product"	"[{""token"": ""magnolol"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""phosphatase and tensin homolog deleted on chromosome 10"", ""start_span"": 32, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"
Furthermore, inhibition of PARP activity, but not of caspase activity, completely prevented magnolol - induced necrosis, suggesting the notion that it might be caused by depletion of intracellular ATP levels due to PARP activation.	"PARP	27	31	Gene_or_gene_product"	"caspase	53	60	Gene_or_gene_product"	"magnolol	92	100	Chemical"	"intracellular	183	196	Immaterial_anatomical_entity"	"ATP	197	200	Chemical"	"PARP	215	219	Gene_or_gene_product"	"[{""token"": ""PARP"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""magnolol"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 183, ""end_span"": 196, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ATP"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Chemical""}, {""token"": ""PARP"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}]"
The cell type specific glycosylation protects Sp1 and HIF1alpha from proteosome degradation and plays an important and novel role in the regulation of VEGF in DCN transfected MCE cells.	"cell	4	8	Cell"	"Sp1	46	49	Gene_or_gene_product"	"HIF1alpha	54	63	Gene_or_gene_product"	"VEGF	151	155	Gene_or_gene_product"	"DCN	159	162	Gene_or_gene_product"	"MCE cells	175	184	Cell"	"[{""token"": ""cell"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""Sp1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Cell""}]"
In this study, we investigated the effects of spironolactone on the prevention of corneal allograft rejection in a MHC class I / II mismatch rat corneal transplant model.	"spironolactone	46	60	Chemical"	"corneal allograft	82	99	Multi"	"MHC class I	115	126	Gene_or_gene_product"	"II	129	131	Gene_or_gene_product"	"rat	141	144	Organism"	"corneal	145	152	Multi"	"[{""token"": ""spironolactone"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""corneal allograft"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Multi""}, {""token"": ""MHC class I"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""corneal"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Multi""}]"
METHODS: Immunohistochemical staining with D2 - 40 and CD34 was performed on formalin - fixed, paraffin - embedded tissue sections of 254 invasive breast tumors of 247 patients with node negative and node positive early breast cancer.	"D2 - 40	43	50	Gene_or_gene_product"	"CD34	55	59	Gene_or_gene_product"	"tissue sections	115	130	Tissue"	"breast tumors	147	160	Cancer"	"patients	168	176	Organism"	"breast cancer	220	233	Cancer"	"[{""token"": ""D2 - 40"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue sections"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""breast tumors"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Cancer""}]"
LVI was correctly identified by D2 - 40 ( D2 - 40 +) in 70 out of 254 tumors ( 28%) as compared to 40 tumors ( 16%) by routine HE staining ( HE +).	"D2 - 40	32	39	Gene_or_gene_product"	"D2 - 40	42	49	Gene_or_gene_product"	"tumors	70	76	Cancer"	"tumors	102	108	Cancer"	"HE	127	129	Chemical"	"HE	141	143	Chemical"	"[{""token"": ""D2 - 40"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""HE"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Chemical""}, {""token"": ""HE"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Chemical""}]"
We conditionally activated N - myc in SH - EP neuroblastoma cells subjected to the trophic stress of serum or nutrient deprivation while changing the expression of Bcl - 2, survivin and FLIP ( L), antiapoptotic molecules often overexpressed in poor prognosis neuroblastomas.	"N - myc	27	34	Gene_or_gene_product"	"SH - EP neuroblastoma cells	38	65	Cell"	"serum	101	106	Organism_substance"	"Bcl - 2	164	171	Gene_or_gene_product"	"survivin	173	181	Gene_or_gene_product"	"neuroblastomas	259	273	Cancer"	"[{""token"": ""N - myc"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - EP neuroblastoma cells"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism_substance""}, {""token"": ""Bcl - 2"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastomas"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Cancer""}]"
Endosialin / TEM 1 / CD248 is a pericyte marker of embryonic and tumor neovascularization.	"Endosialin	0	10	Gene_or_gene_product"	"TEM 1	13	18	Gene_or_gene_product"	"CD248	21	26	Gene_or_gene_product"	"pericyte	32	40	Cell"	"embryonic	51	60	Developing_anatomical_structure"	"tumor	65	70	Cancer"	"[{""token"": ""Endosialin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEM 1"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD248"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}]"
OBJECTIVE: We transfected ovarian cancer cells and administered recombinant plasmid encoding hPNAS - 4 to nude mice bearing ovarian cancer, aiming to evaluate the effect of hPNAS - 4 against ovarian cancer in vitro and in vivo.	"ovarian cancer cells	26	46	Cell"	"hPNAS - 4	93	102	Gene_or_gene_product"	"nude mice	106	115	Organism"	"ovarian cancer	124	138	Cancer"	"hPNAS - 4	173	182	Gene_or_gene_product"	"ovarian cancer	191	205	Cancer"	"[{""token"": ""ovarian cancer cells"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""hPNAS - 4"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""nude mice"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 191, ""end_span"": 205, ""type"": ""Cancer""}]"
The present findings indicate that vandetanib therapy effectively counteracted the aggressive feature of tumor growth resulting from VEGF over - expressing tumor cells and suggest that such tumors may be particularly well suited for anti - VEGF interventions.	"vandetanib	35	45	Chemical"	"tumor	105	110	Cancer"	"VEGF	133	137	Gene_or_gene_product"	"tumor cells	156	167	Cell"	"tumors	190	196	Cancer"	"VEGF	240	244	Gene_or_gene_product"	"[{""token"": ""vandetanib"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}]"
Induction of TSP - 1 mRNA by TGF - beta was attenuated by c - Ski in vitro, and expression of TSP - 1 mRNA was decreased in tumors expressing c - Ski in vivo.	"TSP - 1	13	20	Gene_or_gene_product"	"TGF - beta	29	39	Gene_or_gene_product"	"c - Ski	58	65	Gene_or_gene_product"	"TSP - 1	94	101	Gene_or_gene_product"	"tumors	124	130	Cancer"	"c - Ski	142	149	Gene_or_gene_product"	"[{""token"": ""TSP - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Ski"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""c - Ski"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"
Down syndrome critical region gene 1 ( DSCR - 1) short variant ( DSCR - 1s) is an inhibitor of calcineurin / NFAT signaling encoded by exons 4 - 7 of DSCR1.	"Down syndrome critical region gene 1	0	36	Gene_or_gene_product"	"DSCR - 1	39	47	Gene_or_gene_product"	"DSCR - 1s	65	74	Gene_or_gene_product"	"calcineurin	95	106	Gene_or_gene_product"	"NFAT	109	113	Gene_or_gene_product"	"DSCR1	150	155	Gene_or_gene_product"	"[{""token"": ""Down syndrome critical region gene 1"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""NFAT"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR1"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"
In a mouse model of endotoxemia, DSCR - 1s - deficient mice demonstrated increased sepsis mortality, whereas adenovirus - mediated DSCR - 1s overexpression protected against LPS - induced lethality.	"mouse	5	10	Organism"	"DSCR - 1s	33	42	Gene_or_gene_product"	"mice	55	59	Organism"	"adenovirus	109	119	Organism"	"DSCR - 1s	131	140	Gene_or_gene_product"	"LPS	174	177	Chemical"	"[{""token"": ""mouse"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""DSCR - 1s"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""adenovirus"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Organism""}, {""token"": ""DSCR - 1s"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPS"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Chemical""}]"
Via this binding, nicked beta2GPI attenuates the antiangiogenic functions of AS4. 5 in the proliferation of arterial / venous endothelial cells, in the extracellular matrix invasion and the tube formation of venous endothelial cells, and in vivo angiogenesis.	"nicked beta2GPI	18	33	Gene_or_gene_product"	"arterial	108	116	Cell"	"venous endothelial cells	119	143	Cell"	"extracellular matrix	152	172	Cellular_component"	"tube	190	194	Tissue"	"venous endothelial cells	208	232	Cell"	"[{""token"": ""nicked beta2GPI"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""arterial"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""venous endothelial cells"", ""start_span"": 119, ""end_span"": 143, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Cellular_component""}, {""token"": ""tube"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Tissue""}, {""token"": ""venous endothelial cells"", ""start_span"": 208, ""end_span"": 232, ""type"": ""Cell""}]"
Our previous studies have shown that the neurotransmitter dopamine could inhibit VEGF - induced phosphorylation of VEGF receptor 2 ( VEGFR - 2), endothelial cell proliferation, migration, microvascular permeability, and thus, angiogenesis.	"dopamine	58	66	Chemical"	"VEGF	81	85	Gene_or_gene_product"	"VEGF receptor 2	115	130	Gene_or_gene_product"	"VEGFR - 2	133	142	Gene_or_gene_product"	"endothelial cell	145	161	Cell"	"microvascular	188	201	Tissue"	"[{""token"": ""dopamine"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF receptor 2"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 145, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""microvascular"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Tissue""}]"
In this study we separated weakly acidic phenolic components from other neutral, acidic and basic components of tobacco smoke condensate ( TSC) and observed that phenolic fraction of TSC significantly increased the number of colonies of promotion - sensitive JB6 Cl41 cells that showed anchorage - independent growth on soft agar in response to BPDE ( an ultimate carcinogen produced by metabolic activation of the PAH benzo [ a] pyrene).	"tobacco smoke condensate	112	136	Chemical"	"TSC	139	142	Chemical"	"phenolic fraction	162	179	Chemical"	"TSC	183	186	Chemical"	"JB6 Cl41 cells	259	273	Cell"	"BPDE	345	349	Chemical"	"[{""token"": ""tobacco smoke condensate"", ""start_span"": 112, ""end_span"": 136, ""type"": ""Chemical""}, {""token"": ""TSC"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""phenolic fraction"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""TSC"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Chemical""}, {""token"": ""JB6 Cl41 cells"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Cell""}, {""token"": ""BPDE"", ""start_span"": 345, ""end_span"": 349, ""type"": ""Chemical""}]"
In order to understand the underlying mechanism by which TSC phenolic fraction potentiates BPDE - induced tumorigenicity, we examined its effect on the activation of two transcription factors AP - 1 and NF - kappaB which are known to be influenced by established tumor promoter TPA.	"TSC phenolic fraction	57	78	Chemical"	"BPDE	91	95	Chemical"	"AP - 1	192	198	Gene_or_gene_product"	"NF - kappaB	203	214	Gene_or_gene_product"	"tumor	263	268	Cancer"	"TPA	278	281	Chemical"	"[{""token"": ""TSC phenolic fraction"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""BPDE"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Cancer""}, {""token"": ""TPA"", ""start_span"": 278, ""end_span"": 281, ""type"": ""Chemical""}]"
Attenuation of NF - kappaB activation by TSC phenolic fraction was associated with significant decrease of intracellular PKC substrate phosphorylation in BPDE treated cells.	"NF - kappaB	15	26	Gene_or_gene_product"	"TSC phenolic fraction	41	62	Chemical"	"intracellular	107	120	Immaterial_anatomical_entity"	"PKC	121	124	Gene_or_gene_product"	"BPDE	154	158	Chemical"	"cells	167	172	Cell"	"[{""token"": ""NF - kappaB"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""PKC"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Cell""}]"
However, although beta ( 2) M and MHC class I are expressed on normal hematopoietic cells, which is a potential safety concern, the monoclonal antibodies were selective to tumor cells and did not damage normal cells in vitro or in human - like mouse models.	"MHC class I	34	45	Gene_or_gene_product"	"hematopoietic cells	70	89	Cell"	"tumor cells	172	183	Cell"	"cells	210	215	Cell"	"human	231	236	Organism"	"mouse	244	249	Organism"	"[{""token"": ""MHC class I"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Organism""}]"
Mutations in colonic adenomas, and the frequent losses on 4q described in gastric cancer prompt speculation about the role of CDC4 / FBXW7 in gastric carcinogenesis.	"colonic adenomas	13	29	Cancer"	"4q	58	60	Cellular_component"	"gastric cancer	74	88	Cancer"	"CDC4	126	130	Gene_or_gene_product"	"FBXW7	133	138	Gene_or_gene_product"	"gastric	142	149	Organ"	"[{""token"": ""colonic adenomas"", ""start_span"": 13, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""4q"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Cellular_component""}, {""token"": ""gastric cancer"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""CDC4"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Organ""}]"
In addition, our in vivo studies indicated that the lenti - BI - 1 - infected cells formed obvious tumours, while no tumours were formed by the control cells after subcutaneously injected into nude mice.	"BI - 1	60	66	Gene_or_gene_product"	"cells	78	83	Cell"	"tumours	99	106	Cancer"	"tumours	117	124	Cancer"	"control cells	144	157	Cell"	"nude mice	193	202	Organism"	"[{""token"": ""BI - 1"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""tumours"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cancer""}, {""token"": ""control cells"", ""start_span"": 144, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Organism""}]"
Anti - metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF - kappaB activity and downregulation of PI3K / AKT / small GTPase signals.	"gallic acid	29	40	Chemical"	"gastric cancer cells	44	64	Cell"	"NF - kappaB	88	99	Gene_or_gene_product"	"PI3K	131	135	Gene_or_gene_product"	"AKT	138	141	Gene_or_gene_product"	"small GTPase	144	156	Gene_or_gene_product"	"[{""token"": ""gallic acid"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""gastric cancer cells"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""small GTPase"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"
In the current investigation, we show that p - XSC, but not an equivalent dose of SM, alters molecular targets and induces apoptosis in androgen - responsive LNCaP and androgen - independent LNCaP C4 - 2 human prostate cancer cells.	"p - XSC	43	50	Chemical"	"SM	82	84	Chemical"	"androgen	136	144	Chemical"	"LNCaP	158	163	Cell"	"androgen	168	176	Chemical"	"LNCaP C4 - 2 human prostate cancer cells	191	231	Cell"	"[{""token"": ""p - XSC"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""SM"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""androgen"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""LNCaP"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""androgen"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""LNCaP C4 - 2 human prostate cancer cells"", ""start_span"": 191, ""end_span"": 231, ""type"": ""Cell""}]"
The present study revealed that androgen increases glucose utilization for de novo lipogenesis in LNCaP cells through the activation of HK2 ( hexokinase 2) and activation of the cardiac isoform of PFKFB2 ( 6 - phosphofructo - 2 - kinase / fructose - 2, 6 - bisphosphatase).	"androgen	32	40	Chemical"	"glucose	51	58	Chemical"	"LNCaP cells	98	109	Cell"	"HK2	136	139	Gene_or_gene_product"	"cardiac	178	185	Organ"	"PFKFB2	197	203	Gene_or_gene_product"	"[{""token"": ""androgen"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""LNCaP cells"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""HK2"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiac"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organ""}, {""token"": ""PFKFB2"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"
Activation of PKA ( cAMP - dependent protein kinase) by androgen increased phosphorylation of CREB [ CRE ( cAMP - response element) - binding protein], which in turn bound to CRE on the promoter of the HK2 gene resulting in transcriptional activation of the HK2 gene.	"PKA	14	17	Gene_or_gene_product"	"cAMP - dependent protein kinase	20	51	Gene_or_gene_product"	"androgen	56	64	Chemical"	"CREB	94	98	Gene_or_gene_product"	"HK2	202	205	Gene_or_gene_product"	"HK2	258	261	Gene_or_gene_product"	"[{""token"": ""PKA"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cAMP - dependent protein kinase"", ""start_span"": 20, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""CREB"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK2"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK2"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}]"
Diallyl trisulfide ( DATS) inhibits mouse colon tumor in mouse CT - 26 cells allograft model in vivo.	"Diallyl trisulfide	0	18	Chemical"	"DATS	21	25	Chemical"	"mouse	36	41	Organism"	"colon tumor	42	53	Cancer"	"mouse	57	62	Organism"	"CT - 26 cells	63	76	Cell"	"[{""token"": ""Diallyl trisulfide"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""DATS"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""colon tumor"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""CT - 26 cells"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Cell""}]"
Our study reveals a novel link between HMGA2 and the regulation of human telomerase reverse transcriptase ( hTERT), the catalytic subunit of telomerase, which offers critical insight into how HMGA2 contributes to tumorigenesis.	"HMGA2	39	44	Gene_or_gene_product"	"human	67	72	Organism"	"telomerase reverse transcriptase	73	105	Gene_or_gene_product"	"hTERT	108	113	Gene_or_gene_product"	"telomerase	141	151	Gene_or_gene_product"	"HMGA2	192	197	Gene_or_gene_product"	"[{""token"": ""HMGA2"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 73, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}]"
Treatment with suberoylanilide hydroxamide ( SAHA), a histone deacetylase ( HDAC) inhibitor, causes dose - dependent hTERT reporter activation, mimicking HMGA2 overexpression.	"suberoylanilide hydroxamide	15	42	Chemical"	"SAHA	45	49	Chemical"	"histone deacetylase	54	73	Gene_or_gene_product"	"HDAC	76	80	Gene_or_gene_product"	"hTERT	117	122	Gene_or_gene_product"	"HMGA2	154	159	Gene_or_gene_product"	"[{""token"": ""suberoylanilide hydroxamide"", ""start_span"": 15, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""SAHA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""histone deacetylase"", ""start_span"": 54, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"
We examined the paired tumour and normal - tissue specimens of 86 CRC patients for the occurrence of aberrations in the mutation cluster region ( MCR) of the APC gene and exon 3 of the beta - catenin gene by polymerase chain reaction - single - strand conformation polymorphism ( PCR - SSCP) and / or PCR - direct sequencing.	"tumour	23	29	Cancer"	"tissue specimens	43	59	Tissue"	"CRC	66	69	Cancer"	"patients	70	78	Organism"	"APC	158	161	Gene_or_gene_product"	"beta - catenin	185	199	Gene_or_gene_product"	"[{""token"": ""tumour"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""tissue specimens"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""CRC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""APC"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 185, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"
Although the number of mutations in the APC and beta - catenin genes in our CRC cases was very low, the study confirms the role of epigenetic gene silencing of the pivotal molecular gladiator, APC, of the Wnt pathway in the development of CRC in the Kashmiri population.	"APC	40	43	Gene_or_gene_product"	"beta - catenin	48	62	Gene_or_gene_product"	"CRC	76	79	Cancer"	"APC	193	196	Gene_or_gene_product"	"Wnt	205	208	Gene_or_gene_product"	"CRC	239	242	Cancer"	"[{""token"": ""APC"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRC"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""APC"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRC"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Cancer""}]"
In addition, AglRhz induced activation of caspase - 3 and poly ( ADP - ribose) polymerase ( PARP), and DNA fragmentation in HT - 29 cells, leads to induction of apoptosis as well as suppression of tumorigenicity of HT - 29 cells.	"AglRhz	13	19	Chemical"	"caspase - 3	42	53	Gene_or_gene_product"	"PARP	92	96	Gene_or_gene_product"	"DNA	103	106	Cellular_component"	"HT - 29 cells	124	137	Cell"	"HT - 29 cells	215	228	Cell"	"[{""token"": ""AglRhz"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""caspase - 3"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Cellular_component""}, {""token"": ""HT - 29 cells"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""HT - 29 cells"", ""start_span"": 215, ""end_span"": 228, ""type"": ""Cell""}]"
Surgical specimens from 20 cases of OSCC with lymph node metastasis, 20 cases of OSCC without lymph node metastasis, and 10 cases of normal mucosa were examined by immunohistochemistry.	"specimens	9	18	Multi"	"OSCC	36	40	Cancer"	"lymph node	46	56	Multi"	"OSCC	81	85	Cancer"	"lymph node	94	104	Multi"	"mucosa	140	146	Multi"	"[{""token"": ""specimens"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""OSCC"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Multi""}, {""token"": ""OSCC"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Multi""}, {""token"": ""mucosa"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Multi""}]"
Here we characterized the effects of mutant CK1delta variants with impaired kinase activity on SV40 - induced cell transformation in vitro, and on SV40 - induced mammary carcinogenesis in vivo in a transgenic / bi - transgenic mouse model.	"CK1delta	44	52	Gene_or_gene_product"	"SV40	95	99	Organism"	"cell	110	114	Cell"	"SV40	147	151	Organism"	"mammary	162	169	Organ"	"transgenic / bi - transgenic mouse	198	232	Organism"	"[{""token"": ""CK1delta"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""cell"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""SV40"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Organ""}, {""token"": ""transgenic / bi - transgenic mouse"", ""start_span"": 198, ""end_span"": 232, ""type"": ""Organism""}]"
Both WAP - T mice as well as WAP - mutCK1delta / WAP - T bi - transgenic mice developed breast cancer.	"WAP - T	5	12	Gene_or_gene_product"	"mice	13	17	Organism"	"WAP	29	32	Gene_or_gene_product"	"mutCK1delta	35	46	Gene_or_gene_product"	"WAP - T	49	56	Gene_or_gene_product"	"breast cancer	88	101	Cancer"	"[{""token"": ""WAP - T"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""WAP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Cancer""}]"
Thirty uterine cervix specimens sampled following conization or total hysterectomy were studied using histology, histoenzymology ( vessel phosphatase alkaline activity), and immunohistochemistry ( demonstration of laminin and type IV collagen in epithelium and vessel basement membranes).	"uterine cervix specimens	7	31	Multi"	"vessel	131	137	Multi"	"laminin	214	221	Gene_or_gene_product"	"type IV collagen	226	242	Gene_or_gene_product"	"epithelium	246	256	Tissue"	"vessel basement membranes	261	286	Cellular_component"	"[{""token"": ""uterine cervix specimens"", ""start_span"": 7, ""end_span"": 31, ""type"": ""Multi""}, {""token"": ""vessel"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Multi""}, {""token"": ""laminin"", ""start_span"": 214, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 226, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelium"", ""start_span"": 246, ""end_span"": 256, ""type"": ""Tissue""}, {""token"": ""vessel basement membranes"", ""start_span"": 261, ""end_span"": 286, ""type"": ""Cellular_component""}]"
Our current data suggest that gamma rays worked as an initiator of carcinogenesis in normal human cells, giving rise to chromosome aberrations and immortality, and the Ha - ras oncogene played a role in the progression of the immortally transformed cell population to a neoplastic one showing enhanced colony formation in soft agar and tumorigenicity in nude mice.	"human	92	97	Organism"	"cells	98	103	Cell"	"chromosome	120	130	Cellular_component"	"Ha - ras	168	176	Gene_or_gene_product"	"cell	249	253	Cell"	"nude mice	354	363	Organism"	"[{""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""chromosome"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Cellular_component""}, {""token"": ""Ha - ras"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 249, ""end_span"": 253, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 354, ""end_span"": 363, ""type"": ""Organism""}]"
The proliferative response of bovine retinal capillary endothelial cells to EGF is dependent upon attaching the cells to a matrix of fibronectin.	"bovine	30	36	Organism"	"retinal capillary endothelial cells	37	72	Cell"	"EGF	76	79	Gene_or_gene_product"	"cells	112	117	Cell"	"matrix	123	129	Cellular_component"	"fibronectin	133	144	Gene_or_gene_product"	"[{""token"": ""bovine"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""retinal capillary endothelial cells"", ""start_span"": 37, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""EGF"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Cellular_component""}, {""token"": ""fibronectin"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Each consists of repetitive cycles of interaction with adjacent extracellular matrix components by mediating cellular adhesion, matrix dissolution, and cellular motility to achieve metastasis of cancer cells or neovascularization of tumors.	"extracellular matrix components	64	95	Cellular_component"	"cellular	109	117	Cell"	"matrix	128	134	Cellular_component"	"cellular	152	160	Cell"	"cancer cells	195	207	Cell"	"tumors	233	239	Cancer"	"[{""token"": ""extracellular matrix components"", ""start_span"": 64, ""end_span"": 95, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Cancer""}]"
Emodin, at a 40 - microM concentration, which repressed tyrosine kinase of p185neu, efficiently inhibited both anchorage - dependent and anchorage - independent growth of HER - 2 / neu - overexpressing breast cancer cells.	"Emodin	0	6	Chemical"	"tyrosine	56	64	Amino_acid"	"p185neu	75	82	Gene_or_gene_product"	"HER - 2	171	178	Gene_or_gene_product"	"neu	181	184	Gene_or_gene_product"	"breast cancer cells	202	221	Cell"	"[{""token"": ""Emodin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""tyrosine"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Amino_acid""}, {""token"": ""p185neu"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 202, ""end_span"": 221, ""type"": ""Cell""}]"
Here we examined expression of type IV collagenases in parental LTA and NIH 3T3 cells ( with and without ras) and four metastatic LTA x NIH 3T3 hybrids ( also with and without ras).	"type IV collagenases	31	51	Gene_or_gene_product"	"LTA	64	67	Cell"	"NIH 3T3 cells	72	85	Cell"	"ras	105	108	Gene_or_gene_product"	"LTA x NIH 3T3 hybrids	130	151	Cell"	"ras	176	179	Gene_or_gene_product"	"[{""token"": ""type IV collagenases"", ""start_span"": 31, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""NIH 3T3 cells"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA x NIH 3T3 hybrids"", ""start_span"": 130, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"
Parental NIH 3T3 - derived cells had both 72 kDa and 92 kDa gelatinase activities, and LTA - derived cells had either aberrantly sized approximately 90 kDa activity alone or neither enzyme activity.	"NIH 3T3 - derived cells	9	32	Cell"	"72 kDa	42	48	Gene_or_gene_product"	"92 kDa gelatinase	53	70	Gene_or_gene_product"	"LTA	87	90	Cell"	"cells	101	106	Cell"	"90 kDa	149	155	Gene_or_gene_product"	"[{""token"": ""NIH 3T3 - derived cells"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""72 kDa"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa gelatinase"", ""start_span"": 53, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""90 kDa"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"
The ST3 and BM - 40 / SPARC transcripts were overexpressed in primary colorectal cancers and their liver metastases compared to non - neoplastic mucosa.	"ST3	4	7	Gene_or_gene_product"	"BM - 40	12	19	Gene_or_gene_product"	"SPARC	22	27	Gene_or_gene_product"	"colorectal cancers	70	88	Cancer"	"liver	99	104	Organ"	"mucosa	145	151	Multi"	"[{""token"": ""ST3"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancers"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""mucosa"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Multi""}]"
However, it is completely absent from cells transformed by the oncogene v - myc or v - src and from cells derived from a methylcholanthrene - induced fibrosarcoma.	"cells	38	43	Cell"	"v - myc	72	79	Gene_or_gene_product"	"v - src	83	90	Gene_or_gene_product"	"cells	100	105	Cell"	"methylcholanthrene	121	139	Chemical"	"fibrosarcoma	150	162	Cancer"	"[{""token"": ""cells"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""v - myc"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - src"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""methylcholanthrene"", ""start_span"": 121, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""fibrosarcoma"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Cancer""}]"
Molecular mechanisms of pituitary tumorigenesis were studied using Polymerase chain reaction - single stranded conformational polymorphism with DNA sequencing to identify potential mutations in the ras protooncogenes and the tumor suppressor gene p53 in invasive pituitary adenomas and carcinomas.	"pituitary	24	33	Organ"	"ras	73	76	Gene_or_gene_product"	"tumor	225	230	Cancer"	"p53	247	250	Gene_or_gene_product"	"invasive pituitary adenomas	254	281	Cancer"	"carcinomas	286	296	Cancer"	"[{""token"": ""pituitary"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Organ""}, {""token"": ""ras"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 247, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive pituitary adenomas"", ""start_span"": 254, ""end_span"": 281, ""type"": ""Cancer""}, {""token"": ""carcinomas"", ""start_span"": 286, ""end_span"": 296, ""type"": ""Cancer""}]"
This transporter was expressed on the cell membrane and in the cytoplasm of the tumor cells, but exhibited marked intratumoral and intertumoral variability in the proportions of positive cells and the intensity of staining.	"cell membrane	38	51	Cellular_component"	"cytoplasm	63	72	Organism_substance"	"tumor cells	80	91	Cell"	"intratumoral	114	126	Cancer"	"intertumoral	131	143	Cancer"	"cells	187	192	Cell"	"[{""token"": ""cell membrane"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Organism_substance""}, {""token"": ""tumor cells"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""intratumoral"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""intertumoral"", ""start_span"": 131, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Cell""}]"
The 5T4 antigen is a transmembrane glycoprotein with a 310 amino acid extracellular domain and a 44 amino acid cytoplasmic domain.	"5T4	4	7	Gene_or_gene_product"	"transmembrane	21	34	Cellular_component"	"amino acid	59	69	Amino_acid"	"extracellular	70	83	Immaterial_anatomical_entity"	"amino acid	100	110	Amino_acid"	"cytoplasmic	111	122	Organism_substance"	"[{""token"": ""5T4"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Cellular_component""}, {""token"": ""amino acid"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Amino_acid""}, {""token"": ""extracellular"", ""start_span"": 70, ""end_span"": 83, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""amino acid"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Amino_acid""}, {""token"": ""cytoplasmic"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Organism_substance""}]"
Thus, in 5T4 - transfected CL - S1 murine mammary cells, 5T4 expression is associated with dendritic morphology, accompanied by abrogation of actin / cadherin - containing contacts and increased motility.	"5T4	9	12	Gene_or_gene_product"	"CL - S1 murine mammary cells	27	55	Cell"	"5T4	57	60	Gene_or_gene_product"	"dendritic	91	100	Cell"	"actin	142	147	Gene_or_gene_product"	"cadherin	150	158	Gene_or_gene_product"	"[{""token"": ""5T4"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""CL - S1 murine mammary cells"", ""start_span"": 27, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""dendritic"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""actin"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""cadherin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
The effects of 5T4 expression on morphology and motility are separable since cells transfected with a truncated form of 5T4 cDNA in which the cytoplasmic domain is deleted reveal that the latter is necessary to abrogate actin / cadherin - containing contacts but does not influence the effects on motility.	"5T4	15	18	Gene_or_gene_product"	"cells	77	82	Cell"	"5T4	120	123	Gene_or_gene_product"	"cytoplasmic	142	153	Organism_substance"	"actin	220	225	Gene_or_gene_product"	"cadherin	228	236	Gene_or_gene_product"	"[{""token"": ""5T4"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Organism_substance""}, {""token"": ""actin"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}, {""token"": ""cadherin"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}]"
